Next Article in Journal
Multivalent Carbohydrate-Lectin Interactions: How Synthetic Chemistry Enables Insights into Nanometric Recognition
Previous Article in Journal
Fusarium Toxins in Cereals: Occurrence, Legislation, Factors Promoting the Appearance and Their Management
Article Menu
Issue 5 (May) cover image

Export Article

Open AccessArticle
Molecules 2016, 21(5), 624; doi:10.3390/molecules21050624

The Mechanism by Which Amentoflavone Improves Insulin Resistance in HepG2 Cells

1
School of Pharmacy, Henan University of Traditional Chinese Medicine, Zhengzhou 450046, China
2
Center for Artery Atheroscerosis Research, Havana University of Medical Sciences, Havana 999075, Cuba
3
Collaborative Innovation Center for Respiratory Disease Diagnosis and Treatment and Chinese Medicine Development of Henan Province, Henan University of Traditional Chinese Medicine, Zhengzhou 450046, China
*
Author to whom correspondence should be addressed.
Academic Editor: Derek J. McPhee
Received: 21 January 2016 / Revised: 5 May 2016 / Accepted: 6 May 2016 / Published: 13 May 2016
(This article belongs to the Section Natural Products)
View Full-Text   |   Download PDF [1587 KB, uploaded 13 May 2016]   |  

Abstract

Background: The aim of this study was to explore the mechanism by which amentoflavone (AME) improves insulin resistance in a human hepatocellular liver carcinoma cell line (HepG2). Methods: A model of insulin resistant cells was established in HepG2 by treatment with high glucose and insulin. The glucose oxidase method was used to detect the glucose consumption in each group. To determine the mechanism by which AME improves insulin resistance in HepG2 cells, enzyme-linked immunosorbent assay (ELISA) and western blotting were used to detect the expression of phosphatidyl inositol 3-kinase (PI3K), Akt, and pAkt; the activity of the enzymes involved in glucose metabolism; and the levels of inflammatory cytokines. Results: Insulin resistance was successfully induced in HepG2 cells. After treatment with AME, the glucose consumption increased significantly in HepG2 cells compared with the model group (MG). The expression of PI3K, Akt, and pAkt and the activity of 6-phosphofructokinas (PFK-1), glucokinase (GCK), and pyruvate kinase (PK) increased, while the activity of glycogen synthase kinase-3 (GSK-3), phosphoenolpyruvate carboxylase kinase (PEPCK), and glucose-6-phosphatase (G-6-Pase) as well as the levels of interleukin-6 (IL-6), interleukin-8 (IL-8), tumor necrosis factor-α (TNF-α), and C reactive protein (CRP) decreased. Conclusions: The mechanism by which treatment with AME improves insulin resistance in HepG2 cells may involve the PI3K-Akt signaling pathway, the processes of glucose oxygenolysis, glycogen synthesis, gluconeogenesis and inflammatory cytokine expression. View Full-Text
Keywords: AME; insulin resistance; PI3K-Akt; glucose metabolism; inflammatory cytokines AME; insulin resistance; PI3K-Akt; glucose metabolism; inflammatory cytokines
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Zheng, X.; Ke, Y.; Feng, A.; Yuan, P.; Zhou, J.; Yu, Y.; Wang, X.; Feng, W. The Mechanism by Which Amentoflavone Improves Insulin Resistance in HepG2 Cells. Molecules 2016, 21, 624.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top